Minicells: Versatile vectors for targeted drug or si/shRNA cancer therapy
Authors:
- 1 December 2011
- journal article
- review article
- Published by Elsevier in Current Opinion in Biotechnology
- Vol. 22 (6) , 909-916
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Advances in the field of nanooncologyBMC Medicine, 2010
- Molecular Mechanisms of Resistance to Cetuximab and Panitumumab in Colorectal CancerJournal of Clinical Oncology, 2010
- Combination therapy: Opportunities and challenges for polymer–drug conjugates as anticancer nanomedicinesAdvanced Drug Delivery Reviews, 2009
- Active targeting schemes for nanoparticle systems in cancer therapeuticsAdvanced Drug Delivery Reviews, 2008
- HER2 Inhibition: From Discovery to Clinical PracticeClinical Cancer Research, 2007
- Cancer nanotechnology: opportunities and challengesNature Reviews Cancer, 2005
- Recent advances with liposomes as pharmaceutical carriersNature Reviews Drug Discovery, 2005
- Evaluation of Novel Epidermal Growth Factor Receptor Tyrosine Kinase InhibitorsBreast Cancer Research and Treatment, 2004
- EGFR and cancer prognosisEuropean Journal of Cancer, 2001
- Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegansNature, 1998